# Lin Cheng

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lin-cheng/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,507 |
| Field | SARS-CoV-2 and COVID-19 Research |
| h-index | 22 |
| i10-index | 44 |
| Last Known Institution | Dalian Medical University |
| OpenAlex ID | https://openalex.org/A5030068217 |
| ORCID iD | 0000-0001-8066-527X |
| Works | 104 |

## Researcher papers

- [Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19](https://scholariq.org/papers/single-cell-landscape-of-bronchoalveolar-immune-cells-in-patients-with-covid-19/)
- [Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry](https://scholariq.org/papers/antibody-neutralization-of-sars-cov-2-through-ace2-receptor-mimicry/)
- [Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2](https://scholariq.org/papers/potent-and-protective-ighv3-53-3-66-public-antibodies-and-their-shared-escape/)
- [A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration](https://scholariq.org/papers/a-potent-bispecific-nanobody-protects-hace2-mice-against-sars-cov-2-infection/)
- [Dysregulated hematopoiesis in bone marrow marks severe COVID-19](https://scholariq.org/papers/dysregulated-hematopoiesis-in-bone-marrow-marks-severe-covid-19/)
- [Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies](https://scholariq.org/papers/structural-basis-for-bivalent-binding-and-inhibition-of-sars-cov-2-infection-by/)
- [Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2](https://scholariq.org/papers/interferon-armed-rbd-dimer-enhances-the-immunogenicity-of-rbd-for-sterilizing/)
- [Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses](https://scholariq.org/papers/broadly-neutralizing-and-protective-nanobodies-against-sars-cov-2-omicron/)
- [Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice](https://scholariq.org/papers/tandem-bispecific-neutralizing-antibody-eliminates-hiv-1-infection-in-humanized/)
- [Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants](https://scholariq.org/papers/infection-with-wild-type-sars-cov-2-elicits-broadly-neutralizing-and-protective/)
- [Characterization of the gut virome in patients with nonalcoholic fatty liver disease](https://scholariq.org/papers/characterization-of-the-gut-virome-in-patients-with-nonalcoholic-fatty-liver/)

## Researcher topics

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Poxvirus research and outbreaks](https://scholariq.org/topics/poxvirus-research-and-outbreaks/)
- [Herpesvirus Infections and Treatments](https://scholariq.org/topics/herpesvirus-infections-and-treatments/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

## Researcher university

- [Dalian Medical University](https://scholariq.org/institutions/dalian-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.